3rd Saudi Oncology Hematology Pharmacy Symposium 

(SOHPS 2020)

 

Virtual International Symposium - PART 1

26-27 June 2020

Faculty 

Nagwa Ibrahim, Pharm D, PhD

Chair, 3rd SOHPS 2020

Senior Clinical Pharmacist, Oncology

Prince Sultan Military Medical City

Riyadh, Saudi Arabia

Klaus Meier, Pharm D

President, European Society of Oncology Clinical Pharmacists

Germany

Alexandre Chan, Pharm D, MPH, FCCP, FISOPP, BCPS, BCOP

Professor and Founding Chair, Department of Clinical Pharmacy Practice

University of California, Irvine

Past President, International Society of Oncology Pharmacy Practitioners

Board Member, Multinational Association of Supportive Care in Cancer

United State of America 

Francisco Goncalves, PhD

Director of Healthcare Technologies Management

Luz Saude, SA

Auxiliar Professor, Faculty of Medicine

Porto University, Portugal

Abdullah Alsharm, MD

Medical Director of Comprehensive Cancer Center 

King Fahd Medical City

Riyadh, Saudi Arabia

Judith Smith, Pharm D, BCOP, CPHQ, FCCP, FISOPP

Professor, Department of Obstetrics, Gynecology and Reproductive Sciences

Clinical Pharmacy Specialist

McGovern Medical School

University of Texas, Heath Science Center

Houston, USA 

Majed Alshamrani, Pharm D, BCPS, BCOP

Consultant Clinical Pharmacist

Adult Hematology/Oncology

King Abdul Aziz Medical City

Ministry of National Guard Health Affairs

Jeddah, Saudi Arabia

Hashem Al Hashem. MD

Consultant Medical Oncology

Director for Adult medical oncology fellowship program

King Saud Medical City

Riyadh, Saudi Arabia  

 

Ashraf Farrag, MD, PhD

Consultant Medical Oncology

Prince Sultan Military Medical City

Riyadh, Saudi Arabia

Associate Professor of Clinical Oncology

Assiut University, Egypt

 

Hana Abdullah Al-Abdulkarim, RPh, MSc

Director Drug Policy and Economic Center

National Guards Health Affairs

Riyadh, Saudi Arabia

Fatima Mariki, Pharm D, BCOP, MSc Health Economic

Oncology Specialist Clinical Pharmacist

King Faisal Hospital and Research Center

Riyadh, Saudi Arabia

 

Yazeed AlRuthia, PhD

Associate Professor of Health Policy and Pharmacoeconomics 

Research Coordinator, Pharmacoeconomics Research Unit

College of Pharmacy, King Saud University

Riyadh, Saudi Arabia 

 

Day 1: 26 June 2020

Time: 14:15 to 17:30 Saudi time 

Day 2: 27June 2020

Time: 10:00 am - 11:30 Saudi time

Topics:

Role of immunotherapy in TNBC

Dr. Majed Alshamrani (NGHA-Jeddah)

CDK4/6 inhibitors: what do we have? Any preference?

Dr. Ashraf Farraj (PSMMC)

Sequential treatment in advanced gastric cancer

Dr. Abdullah AlSharm (KFMC)

 

Treatment sequences in advanced CRC

Dr. Hashim Alhashim (KSMC)

20/20 view of the new frontiers in management of ovarian cancer

Prof. Judith Smith (USA)

European Union actions for oncology pharmacists to COVID 19 pandemic

Dr. Klaus Meier (Germany)

Cancer survivorship care during COVID 19 – experience and opportunities

Prof. Alexandre Chan (USA)

 

Oncology Pharmacists action during COVID 19 pandemic: Local experience form PSMMC

Dr. Nagwa Ibrahim (PSMMC)

Lessons from COVID times to the future of healthcare

Prof. Francisco Goncalves (Portugal)

 

How to improve efficiency in oncology

Dr. Hana Alabdulkarim (NGHA)

Pharmacoeconomics in a post COVID world

Prof. Francisco Goncalves (Portugal)

 

 

  • YouTube
  • LinkedIn Social Icon
  • Black Facebook Icon
  • Black Twitter Icon